The Impact of CMV-Seropositive Donor Status on Post-Transplant Outcomes in CMV-Seronegative Kidney Transplant Recipient: A US National Registry Study
Sara Belga(University of British Columbia), William A. Werbel(Johns Hopkins University), Allan B. Massie(Johns Hopkins University), Dorry L. Segev(New York University), M. John Gill(University of Calgary), Mário Rodrigues(Johns Hopkins University), Robin K. Avery(Johns Hopkins University), M. Malki Abidi, Christine M. Durand(University of Maryland, Baltimore)
Cited by 0
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k